Search clinical trials for: rituximab and lenalidomide
Total 269562 results
-
MD Anderson International Spain SACelgene CorporationCompletedChronic Lymphocytic LeukemiaSpain
-
Swiss Group for Clinical Cancer ResearchTerminatedLymphomaSwitzerland, Norway, Sweden
-
Fondazione Italiana Linfomi - ETSActive, not recruiting
-
University of BolognaTerminated
-
Institut Paoli-CalmettesCompletedNon-Hodgkin LymphomaFrance
-
Roswell Park Cancer InstituteCelgeneCompleted
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Withdrawn
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Arbeitsgemeinschaft medikamentoese TumortherapieCompletedLymphoma of the Mucosa Associated Lymphoid Tissue (MALT)Austria
-
Weill Medical College of Cornell UniversityCelgeneCompleted
-
Ruijin HospitalNot yet recruitingLymphoma, Large B-Cell, DiffuseChina
-
Guangdong Provincial People's HospitalGuangzhou First People's Hospital; Foshan First People's Hospital; Huizhou Municipal... and other collaboratorsRecruitingDiffuse Large B Cell Lymphoma | Age Over 80 YearsChina
-
Kim, Seok JinCelltrion; Samyang Biopharmaceuticals CorporationRecruitingPrimary CNS LymphomaKorea, Republic of
-
Arbeitsgemeinschaft medikamentoese TumortherapieCelgene CorporationUnknownChronic Myelomonocytic LeukemiaAustria
-
Chronic Lymphocytic Leukemia Research ConsortiumCelgene CorporationUnknownChronic Lymphocytic Leukemia | CLL | Untreated | First-Line | Front-line | Initial TherapyUnited States
-
EnteromeRecruitingFollicular Lymphoma | Marginal Zone LymphomaUnited States, Italy, Spain
-
Incyte CorporationActive, not recruitingFollicular Lymphoma | Marginal Zone LymphomaFinland, United States, Spain, Korea, Republic of, Canada, Israel, Turkey, United Kingdom, Netherlands, Greece, Italy, France, Taiwan, Germany, Belgium, Japan, Czechia, Switzerland, Ireland, Poland, Ukraine, Australia, Denmark, Hungary, Swede... and more
-
Henan Cancer HospitalRecruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Withdrawn
-
Yan Zhang, MDPeking University First Hospital; Chinese PLA General Hospital; Peking University...Recruiting
-
The Lymphoma Academic Research OrganisationRecruitingMarginal Zone LymphomaFrance
-
University of Wisconsin, MadisonGenentech, Inc.; Celgene CorporationWithdrawnChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL)
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)TerminatedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Tianjin Medical University Cancer Institute and...Recruiting
-
University of ChicagoCelgene CorporationCompleted
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Genentech, Inc.; Brigham and Women's Hospital and other collaboratorsTerminatedWaldenstrom's MacroglobulinemiaUnited States
-
Celgene CorporationTerminatedColorectal CancerAustralia, Belgium, Germany, Italy, Spain, Sweden
-
Hackensack Meridian HealthCelgene CorporationCompletedChronic Lymphocytic Leukemia (CLL)United States
-
Qingdao Central HospitalRecruiting
-
Lund University HospitalMundipharma Pte Ltd.; Roche Pharma AG; CelgeneCompletedMantle Cell LymphomaFinland, Denmark, Norway, Sweden
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruitingNeoplasms by Histologic Type | Lymphoma, Large B-Cell, DiffuseChina
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Celgene CorporationCompletedRefractory/Relapsed Indolent Non-Hodgkin LymphomaUnited States
-
Ruijin HospitalThe First Affiliated Hospital of Nanchang University; Qilu Hospital of Shandong... and other collaboratorsRecruiting
-
Weill Medical College of Cornell UniversityCelgeneCompletedChronic Lymphocytic LeukemiaUnited States
-
German CLL Study GroupRoche Pharma AG; Celgene; Mundipharma Research GmbH & Co KGCompletedChronic Lymphocytic LeukemiaGermany
-
Fondazione Italiana Linfomi ONLUSCompleted
-
Ruijin HospitalActive, not recruitingDiffuse Large B Cell LymphomaChina
-
University of California, San DiegoCelgene CorporationCompletedChronic Lymphocytic Leukemia | CLLUnited States
-
CelgeneThe Lymphoma Academic Research OrganisationActive, not recruitingFollicular LymphomaUnited States, Japan
-
Swiss Group for Clinical Cancer ResearchCompleted
-
David Rizzieri, MDGenzyme, a Sanofi Company; Celgene CorporationCompletedLeukemia, Lymphocytic, Chronic, B-CellUnited States
-
SCRI Development Innovations, LLCGenentech, Inc.; Celgene CorporationCompletedChronic Lymphocytic LeukemiaUnited States
-
Zhejiang Cancer HospitalRecruitingDiffuse Large B Cell LymphomaChina
-
First Affiliated Hospital of Wenzhou Medical UniversityRecruitingDiffuse Large B Cell LymphomaChina
-
Zhejiang Cancer HospitalUnknownAngioimmunoblastic T-cell Lymphoma | Chemotherapy Effect | Chemotherapeutic ToxicityChina
-
The Lymphoma Academic Research OrganisationCelgene CorporationActive, not recruitingFollicular LymphomaSpain, Canada, France, Australia, Italy, Belgium, Germany, Portugal
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Active, not recruitingLymphoma | Neurotoxicity | Therapy-related ToxicityUnited States, Canada
-
National Cancer Institute (NCI)CompletedAnn Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma | Ann Arbor Stage II Grade 3 Non-Contiguous... and other conditionsUnited States
-
University Hospital, LilleCelgene CorporationCompletedWaldenstrom MacroglobulinemiaFrance